1. Introduction
===============

The greater saphenous vein (GSV) remains the most commonly harvested conduit for revascularization in coronary artery bypass grafting (CABG) ([@b1-epj-08-1693], [@b2-epj-08-1693]). The conventional technique for this procedure has long been open vein harvesting (OVH). Several studies have reported that the OVH technique results in post-operative pain, delayed healing, and prolonged hospital stay ([@b3-epj-08-1693]--[@b5-epj-08-1693]). Therefore, in the past decade, a minimally invasive technique has been developed to reduce the surgical trauma associated with OVH and improve patients' satisfaction without disturbing the post-surgical outcomes ([@b3-epj-08-1693]--[@b5-epj-08-1693]). There is strong evidence to suggest that the endoscopic vein harvesting (EVH) technique can reduce post-operative infections, pain, mobility restriction, and the duration of hospital stays ([@b6-epj-08-1693]). In preliminary studies, no significant differences in graft patency were observed between the OVH and EVH techniques within six months of the procedures ([@b7-epj-08-1693]). However, in recent studies, it has been suggested that EVH may be accompanied by reduced graft patency ([@b6-epj-08-1693]). From the histological perspective, EVH has been proven to be very similar to the OVH technique; yet certain studies focusing on changes in the endothelial cellular surface are inconsistent with these findings. In a recent study, EVH was associated with a higher rate of venous graft failure and higher rates of mortality, myocardial infarction, and the need for revascularization during the first year after the surgery ([@b3-epj-08-1693]).

Since post-op angiographic studies are not routinely performed, we decided to perform this study on elective, off-pump CABG candidates who made their own decisions to undergo the techniques. The aim of this study was to compare the clinical and pathological outcomes of OVH and EVH in patients who underwent the coronary artery bypass grafting procedure. In addition to the clinical and pathological outcomes, we compared the mean fees for the hospital stays for the EVH and OVH groups.

2. Material and Methods
=======================

2.1. Study setting
------------------

In this cohort study performed from October 2013 through September 2014, all patients scheduled for off-pump CABG in the Cardiac Surgery Ward of Imam Reza Medical were enrolled. Those undergoing CABG for the first time entered either the OVH group (86 cases) or EVH group (87 cases) based on their own decision-making. Patients were included in this study if they were more than 18 years old and scheduled for an elective off-pump CABG for the first time. Patients who also were also candidates for heart-valve surgery, had leg or other ulcers, had active bacterial infections, had simultaneous EVH and OVH, and those who died during surgery were excluded from the study. All operations were performed by a well-experienced surgeon in a single, well-equipped center. The aim of surgery was to obtain complete revascularization by using the graft obtained from the great saphenous vein or the left internal mammalian artery. The anesthesia protocol was similar for all subjects.

2.2. Endoscopic vein harvesting technique
-----------------------------------------

EVH was performed in group A using the Vaso-View system (Open carbon dioxide (CO~2~), Sorin Group Co). Dissection and visualization are possible in this exclusive technique in the presence of CO~2~. Provision of cases was the same with peripheral readiness in order to open harvesting. Openings were performed in the center on the upper and/or the bottom part of the knee through a small cut of 1.5 to 2.5 cm, in accordance with the required length of selected vein; cutting was not done in the region of the knee flexor. Harvesting was conducted primarily to the groin region in order to get the enough vessel length ([@b24-epj-08-1693]). Bipolar cauterizing scissors were used for splitting the lateral branches when the peripheral vein was removed. A small cut was made close to the origin on the basis of endoscopic vision on saphenous vein to seal, freeze, and split the vessel for removal and preparation. After that, the lateral branches were closed and 7-0 monofilament prolene sutures were used, if required. Endoscopic dissection was done beneath the leg away from the center when an extra length of vessel was required. Typically, two or three pieces of the saphenous vein can be removed with each measuring about 15 cm ([@b24-epj-08-1693]). The lesions of the leg were examined closely for any bleeding, and they were kept open to reverse the effects of heparin. The removed regions were rubbed lightly in order to detect any bleeding or clotting, and, then, absorbable subcutaneous and subcuticular sutures were used to close the area. The wound was bandaged with elastic ACE™ wrapfor 48 hours without draining.

2.3. Open operative Technique of vein harvesting (OVH)
------------------------------------------------------

Group B patients underwent conventional open vein harvesting. Long cutting were carried out in the saphenous vein area depending on the required number and length of vein grafts ([@b24-epj-08-1693]). When the vessel was visible, lateral branches were closed or clipped on both the case side and the graft side. Bipolar cauterizing scissors was used to divide the vein branches. The open leg wound was checked for hemostasis ([@b24-epj-08-1693]). The incisions were closed in layers by absorbable sutures and then ended by a subcuticular closure. Finally, the wound was wrapped with cotton gauze, and an ACE™ wrap was applied to the entire leg for 48 hours. The open leg wound is then checked for hemostasis and irrigated with saline solution.

2.4. Studied variables
----------------------

Demographic data, such as age, gender, body mass index (BMI), positive medical history of chronic obstructive pulmonary disease (COPD), asthma, transient ischemic attack (TIA), and diabetes were mentioned in each patient's history. Then, echocardiographic reports for ventricular ejection fraction (EF %), baseline serum creatinine (mg/dL), and hematocrit levels (%) were recorded for all patients. Then we recorded the circumference (cm) of the ankle of the target leg for harvesting leg, and pre-operative intra-aortic balloon pump (IABP) use was recorded. During the surgery, the mean duration (min), the mean blood products required during the operation, and the mean number of grafts performed were entered on the patients' records for both groups. Surgical outcomes were the length of the incision on the leg (cm), the mean harvesting time (min), and the length of the harvested vein (cm). During the surgery, a specimen of the harvested vein was sent for pathological examination. Patients were followed up on the second day of their stay in the post-surgical intensive care unit (ICU) and on the last day of their stay in the post-surgical ward. Also, all patients were monitored for six weeks. ICU and ward observed clinical outcomes were as follows: the circumference (cm) of the ankle of the harvesting leg, pain score (by visual analog scale), serum albumin level (mg/dL), serum creatinine level (mg/dL), positive troponin levels (n), number of transfusion blood pack cells, cardiac arrhythmia, cerebrovascular accident (CVA), IABP use, re-operation rate, and death rate. Mean hospital stay and the fees for the hospital stays also were compared for the two groups. All patients were monitored for six weeks for the circumference of the ankle of the leg of harvested vein, the pain score, and the rate of wound infections.

2.5. Research ethics
--------------------

The study protocol was approved by the Ethics Committee of Mashhad University of Medical Sciences and described to all patients. An informed consent was taken from each participant prior to entering the study.

2.6. Statistical analyses
-------------------------

SPSS version 17.0 (SPSS, Inc., Chicago, Illinois, United States of America) software was used to analyze the data. The paired sample t-test, the independent t-test, their non-parametric equivalents, and the chi-squared test were used as appropriate. The significance level was set at p \< 0.05.

3. Results
==========

3.1. General findings
---------------------

In total, 173 patients were studied. The demographic characteristics of the two groups as they entered the study are provided in [Table 1](#t1-epj-08-1693){ref-type="table"}. Para clinic studies, including ventricular ejection fraction (EF %) (OVH vs. EVH: 44.3 ± 11.6 vs. 50.5 ± 12.1; p = 0.092), serum creatinine (mg/dL) (OVH vs. EVH: 1.1 ± 0.7 vs. 1.1 ± 0.4; p = 0.625), and hematocrit levels (%) (OVH vs. EVH: 40.5 4.9 vs. 38.1 ± 4.8; p = 0.312) on the pre-op day showed no significant difference between the two groups. Moreover, the two groups of OVH and EVH were similar regarding the mean duration of surgery (min) (OVH vs. EVH: 263.2 ± 66.3 vs. 256.8 ± 60.4; p = 0.412) and the mean blood products required during the operation (n) (OVH vs. EVH: 1.0 ± 1.3 vs. 1.0 ± 1.2; p = 0.734). Among the 173 patients who underwent CABG, 584 grafts were performed with a mean number of 3.37 grafts per patient, indicating no meaningful difference between the OVH and EVH groups (OVH vs. EVH: 3.2 ± 0.7 vs. 3.4 ± 0.6; p = 0.061)

3.2. Comparison of surgical outcomes
------------------------------------

The lengths of the incisions in the legs of the EVH group were significantly less than those in the OVH group, showing a meaningful difference (3.719 ± 3.66 vs. 16.963 ± 45.92 cm, p\<0.001). The mean harvesting time also was significantly less in the EVH group than in the OVH group (16.518 ± 36.55 vs. 23.680 ±56.57 min, p \< 0.001). Accordingly, the length of the harvested vein in the EVH group was less than that in the OVH group (14.440 ± 35.59 vs. 15.932 ± 44.47, p = 0.009). The most common locations for vein harvesting in both groups were above and below the knee (86.46% vs. 86.40%). However, in the OVH group, the most commonly used location was below the knee, whereas it was above the knee in the EVH group, showing a meaningful difference (p = 0.01).

3.3. Comparison of post-op complications in the ICU and during hospitalization in the cardiac surgery ward
----------------------------------------------------------------------------------------------------------

In the ICU, no significant difference was found between the EVH and OVH groups considering the studied variables in their post-op ICU stay ([Table 2](#t2-epj-08-1693){ref-type="table"}). During hospitalization in the cardiac surgery ward, no significant difference was found between the two groups considering the studied variables in post-op ward stay ([Table 3](#t3-epj-08-1693){ref-type="table"}). The only difference between the two groups at the end of hospital stay was the hospital fees ([Table 3](#t3-epj-08-1693){ref-type="table"}).

3.4. Six-week follow-up outcomes
--------------------------------

In the sixth post-op week, the circumference (cm) of the ankle of the leg of harvested vein (OVH vs. EVH: 23.7 ± 1.5 vs. 23.4 ± 1.4; p = 0.309) showed no meaningful difference between the two groups. Pain score was significantly less in the EVH group than in the OVH group (OVH vs. EVH: 1.3 ± 0.8 vs. 0.9 ± 1.08; p = 0.02). Also, no cases of wound infection were observed in either group.

3.5. Pathological outcome
-------------------------

The vein grafts taken in the two groups showed no meaningful difference regarding their pathologic status based on endothelia injury (OVH vs. EVH: 2.3% vs. 0.0%; p = 0.241) and intimal fibrosis (OVH vs. EVH: 8.1% vs. 2.3%; p = 0.091).

4. Discussion
=============

Abundant evidence has emerged in the recent years emphasizing that EVH is accompanied with a lower rate of leg-wound morbidity, better cosmetic results, and improved patient satisfaction ([@b1-epj-08-1693], [@b8-epj-08-1693], [@b9-epj-08-1693]). Despite all such advantages, there are still certain concerns regarding the potential ability of this technique to damage the endothelial integrity of the vein ([@b10-epj-08-1693]). However, the results of our study showed that EVH did not cause any undesired clinical outcomes and the patients experienced less pain than the OVH group. In this study, the post-op pain score during the 6-week follow-up period in the EVH group was significantly less than the OVH group. In other similar studies that also have used the VAS for pain assessment, patients undergoing EVH rated their experience of pain on a 0--10 scale two points lower throughout the entire post-operative period and were pain-free a few days earlier than the OVH group ([@b5-epj-08-1693], [@b11-epj-08-1693], [@b12-epj-08-1693]). Patients undergoing EVH due to experiencing less pain had shorter time to mobilization ([@b12-epj-08-1693], [@b13-epj-08-1693]). In the study by Cheng et al. (31), the rate of pain (23.1% vs. 6.7%), neuralgia (24.3% vs. 7.1%), and patient satisfaction (49% vs. 75%) were in a better status in the EVH than in the OVH group.

One of the other complications of vein harvesting is infection at the site of the incision. Various studies have indicated that the rate of infection in the OVH group varies between 2--25%, resulting in significant clinical complications and additional costs to the healthcare system ([@b3-epj-08-1693]). In a meta-analysis by Athanasiou et al. of eleven RCTs, the EVH technique was associated with a significantly lower rate of infection at the harvesting site than OVH (OR = 0.22, p \< 0.00001) ([@b15-epj-08-1693]). In another meta-analysis including 35 studies, the EVH group again had a lower infection rate (p \< 0.0001) ([@b16-epj-08-1693]). In another study by Raja et al. in 2013 ([@b3-epj-08-1693]) on 411 CABG patients, the rate of infection at the harvesting site was followed up for four years. It was reported that the EVH technique almost eliminates the probability of infection at this site when compared to the OVH technique (1.13% vs 1.3%, p \< 0.001). The reason may be due to the smaller incision and the safe transfer of tissue in this surgical method. Another less important aspect may be due to preserved tissue perfusion and a lower likelihood of creating vital tissue flaps. However, the highlight of the current study was the zero infection rate in the 6-week follow-up period. This lower rate of infection in the EVH technique compared to OVH is of particular value in diabetic and obese patients and those with peripheral arterial diseases in whom EVH is considered the method of choice ([@b17-epj-08-1693], [@b18-epj-08-1693]). Irrespective of the harvesting site's infection rate, which has always been a major concern, complications related to the quality of the harvested vein, which, by closing the graft, can cause serious complications in other organs, is of great importance as well. In the current study the two groups were compared regarding heart, kidney, and cerebral complications during hospitalization, and there were no meaningful differences. Myocardial infarction (MI) is the most important complication, and it is an indicator of the graft's patency. In this study, similar to others, no difference was seen in the rate of MI in the short-term. In a meta-analysis by Satry et al. in 2013 ([@b16-epj-08-1693]) that included twelve studies and 3,872 patients, no difference was reported in the rate of MI after the operation by either technique (SR risk: 0.87; 95% CI: 0.68--1.11; p = 0.26).

One of the other important factors in estimating the safety of a certain technique is investigating the short-, mid- and long-term mortality. Our study showed no difference in mortality during hospitalization and the 6-week follow-up between the two groups. This also was reported in the few meta-analyses performed comparing EVH and OVH. Yet, more studies are required regarding this issue in order to obtain more precise results, especially in short- and mid-term follow ups. Another important aspect of the current study is the therapeutic costs for which higher costs were achieved in the EVH group compared to OVH. It seems that this is mostly related to the cost of the technique itself. According to the few studies that have investigated this issue, it has been observed that the shorter time to ambulation and the lower rate of leg wound morbidity result in shortened hospital stay and lower medical costs in the EVH group ([@b3-epj-08-1693]). However, the two we studied showed no meaningful difference regarding the lengths of their hospital stays. Despite the increasing recognition of the benefits of the EVH technique, the quality of the harvested vein is still a major concern, because endothelial injury affects the graft opening following CABG. Studies in this respect have controversial results; Hussaini et al. reported no difference in the structural and functional viability of the saphenous vein endothelium between the EVH and OVH groups, yet they stated that the vasomotor function may decrease ([@b19-epj-08-1693]). Wang et al. also published similar results ([@b20-epj-08-1693]). Andreasen's study in 2015 showed that over the past 6.3 years, the majority of vein graft failures were significantly detected by EVH rather than OVH without any differences in long-term clinical outcomes ([@b21-epj-08-1693]). Angiographic follow-up results had no difference with clinical outcomes in cases with open versus endoscopic harvesting for coronary bypass surgery ([@b23-epj-08-1693]). The EVH is an ordinary technique to train for removing vein conduit in CABG ([@b24-epj-08-1693]). These findings led to increases in endoscopic vein harvesting (EVH). Reduction in wound complications, satisfaction of recovery, shorter durations of admission, and reduced post-operative pain at the opening area after EVH have been reported when EVH and OVH were compared ([@b24-epj-08-1693]). The 2014 Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Guidelines on Myocardial Revascularization addressed the methods of conduit harvest and issued a Class IIa Level A recommendation for EVH. This recommendation, which represents the first formal recommendation for EVH by ESC/EACTS, was based on data from meta-analyses as well as randomized trials, noting that nearly all studies documented reductions in wound infection and impaired healing, and the Guidelines also asserted that the most recent data do not demonstrate inferior clinical outcomes with EVH. The recommendation based on 2014 ESC/EACTS Guidelines about EVH is "Endoscopic vein harvesting should be considered to reduce the incidence of leg wound complications" ([@b25-epj-08-1693]). Moreover, in this study the vein grafts taken in the two groups showed no meaningful difference regarding their pathological findings (p = 0.241).

This study had two main limitations. First, we could not do a post-operative control angiography or CT-angiography for evaluating the grafts patency, because there was no evidence of graft failure in our studied population. So, we were not able to publish the comparison of grafts patency between two groups of EVH and OVH. The second limitation was the short time of the follow-up. We recommend to the other researchers to compare the clinical outcomes of EVH and OVH over longer follow-up periods.

5. Conclusions
==============

The findings of the current study revealed that the harvesting time is generally shorter in the EVH technique in contrast to several other studies. This discrepancy in the results may be due to the experience of the technicians and the equipment used for this purpose. A shorter harvesting time results in a shorter period of post-op care regarding leg-wound morbidity. It seems that we have once again illustrated an important link between minimally-invasive great saphenous vein harvesting and improved tissue healing when compared to conventional open surgery. However, additional research is required to investigate the cosmetic outcomes, hospital costs, and cost-efficiency further; more importantly, long-term graft patency should be investigated in the EVH technique. Taking into consideration the large number of CABG procedures performed in our region using the EVH technique, its training course should be further valued and emphasized to improve the quality of vein grafts besides causing minimal injury to the surrounding tissue.
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###### 

Demographic characteristics of the OVH and EVH groups at study entrance

  Variable                                             OVH[\*](#tfn1-epj-08-1693){ref-type="table-fn"} (n=86)   EVH[\*\*](#tfn2-epj-08-1693){ref-type="table-fn"} (n=87)   p-value   
  ---------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------- --------- -------
  Age (yrs)                                            59.98 ± 10.49                                            59.36 ± 8.207                                              0.665     
  Body Mass Index                                      Normal                                                   43.5%                                                      40.5%     0.969
  Overweight                                           40%                                                      41.7%                                                                
  Obese                                                15.3%                                                    15.5%                                                                
  Sex                                                  Male                                                     62.4%                                                      65.5%     0.666
  Female                                               37.6%                                                    34.5%                                                                
  COPD                                                 1.2%                                                     1.1%                                                       1.00      
  Asthma                                               2.3%                                                     3.4%                                                       1.00      
  Smoking                                              33.7%                                                    31%                                                        0.706     
  Transient Ischemic Attack                            16.3%                                                    4.7%                                                       0.023     
  Diabetes                                             37.2%                                                    43%                                                        0.437     
  Pre-operation IABP^\*\*\*^ use                       4.7%                                                     2.3%                                                       0.682     
  The ankle circumference of the harvesting leg (cm)   23.66 ± 2.58                                             23.60 ± 1.82                                               0.841     

OVH: Open Vein Harvesting,

EVH: Endoscopic Vein Harvesting, IABP: Intra-Aortic Balloon Pump

###### 

Clinical outcome of the OVH and EVH groups in post-surgery intensive care units (ICU)

  Variable                                                        OVH (n=86)   EVH (n=87)   p-value
  --------------------------------------------------------------- ------------ ------------ ---------
  The ankle circumference of the harvesting leg, cm (Mean ± SD)   24.0 ± 2.5   24.1 ± 2.0   0.319
  Pain score, (Mean ± SD)                                         2.0 ± 1.6    1.6 ± 1.4    0.058
  Serum Albumin level, mg/dL (Mean ± SD)                          3.2 ± 0.4    3.2 ± 0.3    0.514
  Positive Troponin, n (%)                                        0            0            \-
  Serum Creatinine level, mg/dL (Mean ± SD)                       1.1 ± 0.7    1.1 ± 0.5    0.691
  Blood Pack cell infusion, n (%)                                 39 (45.3%)   33 (37.9%)   0.734
  Cardiac arrhythmia                                                                        
  Premature ventricular contractions (PVCs), n (%)                11 (12.7%)   5 (5.7%)     0.115
  Ventricular tachycardia (VT), n (%)                             1 (1.1%)     0            0.494
  Atrial Fibrillation (AF), n (%)                                 2 (2.3%)     1 (1.1%)     0.621
  Cerebrovascular accident (CVA), n (%)                           0            0            \-
  Intra-aortic Balloon Pump (IABP) use, n (%)                     9 (10.4%)    8 (8.6%)     0.803
  Re-operation                                                    3 (3.5%)     5 (5.7%)     0.720
  Death, n (%)                                                    3 (3.5%)     2 (2.2%)     0.619

OVH: Open Vein Harvesting, EVH: Endoscopic Vein Harvesting

###### 

Clinical outcome of the OVH and EVH groups in post-surgery hospital stay in cardiac surgery ward

  Variable                                                        OVH (n=83)   EVH (n=85)   p-value
  --------------------------------------------------------------- ------------ ------------ ---------
  The ankle circumference of the harvesting leg, cm (Mean ± SD)   22.7 ± 1.7   23.2 ± 1.6   0.077
  Pain score, (Mean ± SD)                                         1.6 ± 1.3    1.2 ± 1.1    0.003
  Serum Albumin level, mg/dL (Mean ± SD)                          3.2 ± 0.4    3.2 ± 0.3    0.514
  Positive Troponin, n (%)                                        0            0            \-
  Serum Creatinine level, mg/dL (Mean ± SD)                       1.7 ± 0.8    1.1 ± 0.8    0.922
  Blood Pack cell infusion, n (%)                                 0            0            0
  Cardiac arrhythmia                                                                        
  Premature ventricular contractions (PVCs), n (%)                1 (1.2%)     0            0.497
  Ventricular tachycardia (VT), n (%)                             0            0            \-
  Atrial Fibrillation (AF), n (%)                                 1 (1.2%)     0            0.497
  Cerebrovascular accident (CVA), n (%)                           1 (1.2%)     0            0.497
  Intra-aortic Balloon Pump (IABP) use, n (%)                     0            0            \-
  Re-operation                                                    0            0            \-
  Death, n (%)                                                    0            0            \-
  Hospital Stay, day (Mean ± SD)                                  8.5 ± 3.3    8.4 ± 3.2    0.088
  Hospital Stay Fee, Milion Tomman (Mean ± SD)                    5.8 ± 4.7    7.3 ± 2.0    0.008

OVH: Open Vein Harvesting, EVH: Endoscopic Vein Harvesting
